Immunopathology & Immunotherapy

Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye DiseaseA Randomized Clinical Trial

Francisco Amparo, MD, MSc; Mohammad H. Dastjerdi, MD; Andre Okanobo, MD; Giulio Ferrari, MD; Leila Smaga, BSc; Pedram Hamrah, MD; Ula Jurkunas, MD; Debra A. Schaumberg, ScD, OD, MPH; Reza Dana, MD, MPH, MSc

JAMA Ophthalmol. 2013;131(6):715-723.

doi:10.1001/jamaophthalmol.2013.195.

link to press release: http://blog.bostonsight.org/index.php/2013/06/biologic-medication-shows-potential-for-easing-dry-eye-symptoms/?goback=.gde_2812520_member_254002384